<?xml version="1.0" encoding="UTF-8"?>
<html xmlns="http://www.w3.org/1999/xhtml">
 <head charset="UTF-8"/>
 <style> * { font-family : helvetica;} .font17 { font-size : 17; } .font26 { font-size : 26; } .font10 { font-size : 10; } .font11 { font-size : 11; } .font12 { font-size : 12; } .font13 { font-size : 13; } .font30 { font-size : 30; } .font14 { font-size : 14; }</style>
 <body>
  <p>
   <span class="font30">the </span>
   <span class="font26">and </span>
   <span class="font17">PDE </span>
   <span class="font14">with </span>
   <span class="font14">[]. </span>
   <span class="font13">for </span>
   <span class="font12">The </span>
   <span class="font12">are </span>
   <span class="font12">were </span>
   <span class="font12">PDE, </span>
   <span class="font12">compounds </span>
   <span class="font12">reported </span>
   <span class="font12">that </span>
   <span class="font12">this </span>
   <span class="font12">{background </span>
   <span class="font11">natural </span>
   <span class="font11">inhibitors </span>
   <span class="font11">was </span>
   <span class="font11">margin </span>
   <span class="font11">other </span>
   <span class="font11">phosphodiesterase </span>
   <span class="font11">{border-style </span>
   <span class="font11">against </span>
   <span class="font11">Figure </span>
   <span class="font11">px;} </span>
   <span class="font11">#ffffff;} </span>
   <span class="font11">also </span>
   <span class="font11">selective </span>
   <span class="font11">activity </span>
   <span class="font11">have </span>
   <span class="font11">their </span>
   <span class="font11">Alzheimerâ€™s </span>
   <span class="font11">al. </span>
   <span class="font11">been </span>
   <span class="font11">from </span>
   <span class="font11">highlighted </span>
   <span class="font11">interaction </span>
   <span class="font11">structure </span>
   <span class="font11">studied </span>
   <span class="font11">such </span>
   <span class="font11">effects </span>
   <span class="font11">inhibitor </span>
   <span class="font10">its </span>
   <span class="font10">structural </span>
   <span class="font10">structures </span>
   <span class="font10">Chemical </span>
   <span class="font10">This </span>
   <span class="font10">[,]. </span>
   <span class="font10">authors </span>
   <span class="font10">inhibition </span>
   <span class="font10">investigated </span>
   <span class="font10">molecules </span>
   <span class="font10">selectivity </span>
   <span class="font10">binding </span>
   <span class="font10">chemical </span>
   <span class="font10">residues </span>
   <span class="font10">study </span>
   <span class="font10">PDEs </span>
   <span class="font10">clinical </span>
   <span class="font10">currently </span>
   <span class="font10">cyclic </span>
   <span class="font10">inhibitors, </span>
   <span class="font10">involved </span>
   <span class="font10">more </span>
   <span class="font10">most </span>
   <span class="font10">novel </span>
   <span class="font10">nucleotide </span>
   <span class="font10">promising </span>
   <span class="font10">protein </span>
   <span class="font10">(Figure </span>
   <span class="font10">Natural </span>
   <span class="font10">PDE. </span>
   <span class="font10">Phosphodiesterase </span>
   <span class="font10">brain </span>
   <span class="font10">cGMP </span>
   <span class="font10">dementia </span>
   <span class="font10">different </span>
   <span class="font10">isoforms </span>
   <span class="font10">pattern </span>
   <span class="font10">px; </span>
   <span class="font10">{font-family </span>
   <span class="font10">cAMP </span>
   <span class="font10">cognitive </span>
   <span class="font10">compound </span>
   <span class="font10">compounds, </span>
   <span class="font10">derivatives </span>
   <span class="font10">development </span>
   <span class="font10">docking </span>
   <span class="font10">features </span>
   <span class="font10">font-size </span>
   <span class="font10">inhibitory </span>
   <span class="font10">isoform </span>
   <span class="font10">models </span>
   <span class="font10">potential </span>
   <span class="font10">showed </span>
   <span class="font10">specific </span>
   <span class="font10">target </span>
   <span class="font10">targeting </span>
   <span class="font10">two </span>
   <span class="font10">(PDE) </span>
   <span class="font10">BAY </span>
   <span class="font10">Inhibitors </span>
   <span class="font10">Moreover, </span>
   <span class="font10">[], </span>
   <span class="font10">between </span>
   <span class="font10">class </span>
   <span class="font10">double; </span>
   <span class="font10">expression </span>
   <span class="font10">green </span>
   <span class="font10">growing </span>
   <span class="font10">hand, </span>
   <span class="font10">human </span>
   <span class="font10">interacting </span>
   <span class="font10">labeled </span>
   <span class="font10">molecular </span>
   <span class="font10">nature-inspired </span>
   <span class="font10">neurodegeneration </span>
   <span class="font10">peculiar </span>
   <span class="font10">predicted </span>
   <span class="font10">research </span>
   <span class="font10">role </span>
   <span class="font10">view </span>
   <span class="font10">(PDB </span>
   <span class="font10">(b). </span>
   <span class="font10">Compounds </span>
   <span class="font10">Detailed </span>
   <span class="font10">IBMX </span>
   <span class="font10">ID: </span>
   <span class="font10">Med. </span>
   <span class="font10">Medicinal </span>
   <span class="font10">Prod. </span>
   <span class="font10">above, </span>
   <span class="font10">among </span>
   <span class="font10">antioxidant </span>
   <span class="font10">being </span>
   <span class="font10">border-color </span>
   <span class="font10">border-width </span>
   <span class="font10">but </span>
   <span class="font10">catalytic </span>
   <span class="font10">chain </span>
   <span class="font10">chiral </span>
   <span class="font10">compound, </span>
   <span class="font10">connection, </span>
   <span class="font10">demonstrated </span>
   <span class="font10">discussed </span>
   <span class="font10">disease </span>
   <span class="font10">enzyme </span>
   <span class="font10">found </span>
   <span class="font10">further </span>
   <span class="font10">hydrophobic </span>
   <span class="font10">levels </span>
   <span class="font10">ligands </span>
   <span class="font10">literature </span>
   <span class="font10">magnesium </span>
   <span class="font10">named </span>
   <span class="font10">new </span>
   <span class="font10">over </span>
   <span class="font10">pocket </span>
   <span class="font10">scaffold </span>
   <span class="font10">several </span>
   <span class="font10">similar </span>
   <span class="font10">small </span>
   <span class="font10">solid; </span>
   <span class="font10">some </span>
   <span class="font10">studies </span>
   <span class="font10">when </span>
   <span class="font10">will </span>
   <span class="font10">zinc </span>
   <span class="font10">{font-style </span>
   <span class="font10">{font-weight </span>
   <span class="font10">âˆ’. </span>
   <span class="font10">(a). </span>
   <span class="font10">G.R. </span>
   <span class="font10">Interacting </span>
   <span class="font10">Interestingly, </span>
   <span class="font10">PDEA </span>
   <span class="font10">PF- </span>
   <span class="font10">Phe </span>
   <span class="font10">Res../.. </span>
   <span class="font10">Targeting </span>
   <span class="font10">advantage </span>
   <span class="font10">asymmetry </span>
   <span class="font10">based </span>
   <span class="font10">biochemical </span>
   <span class="font10">bold </span>
   <span class="font10">computational </span>
   <span class="font10">courier; </span>
   <span class="font10">data </span>
   <span class="font10">developing </span>
   <span class="font10">drug </span>
   <span class="font10">em; </span>
   <span class="font10">expressed </span>
   <span class="font10">extracts </span>
   <span class="font10">green. </span>
   <span class="font10">has </span>
   <span class="font10">increasing </span>
   <span class="font10">inhibitors. </span>
   <span class="font10">known </span>
   <span class="font10">light </span>
   <span class="font10">limited </span>
   <span class="font10">memory </span>
   <span class="font10">modified </span>
   <span class="font10">must </span>
   <span class="font10">observed </span>
   <span class="font10">orientation </span>
   <span class="font10">particular, </span>
   <span class="font10">plant </span>
   <span class="font10">pomiferin </span>
   <span class="font10">presence </span>
   <span class="font10">pt;} </span>
   <span class="font10">purple </span>
   <span class="font10">pyrazolopyrimidinone </span>
   <span class="font10">represented </span>
   <span class="font10">results </span>
   <span class="font10">retrieved </span>
   <span class="font10">review </span>
   <span class="font10">synthetic </span>
   <span class="font10">system </span>
   <span class="font10">therapeutic </span>
   <span class="font10">these </span>
   <span class="font10">towards </span>
   <span class="font10">trials </span>
   <span class="font10">unique </span>
   <span class="font10">values </span>
   <span class="font10">vasorelaxant </span>
   <span class="font10">within </span>
   <span class="font10">xanthines </span>
  </p>
 </body>
</html>
